Cyclana Bio
PrivateLast Round
pre_seed
Oct 20, 2025
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cyclana Bio operates in Healthcare & Life Sciences and is based in Cambridge. Its latest recorded funding round was a pre_seed round in October 2025.
Cyclana Bio is a biotechnology company that develops a therapeutic discovery platform using whole-tissue models and AI-driven data integration to identify treatments for endometriosis and other chronic inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cyclana Bio Comparables
Compare Cyclana Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Metri Bio | 90% | |
| GynQura Therapeutics | 87% | |
| EndoGene.Bio | 79% |
For institutional investors. Book with your work email.
Cyclana Bio Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cyclana Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| NFX | pre_seed |
| Cocoa Ventures | pre_seed |
| Eka Ventures | pre_seed |
| Wilbe Capital | pre_seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Sep 28, 2026
Open roles increased from 0 to 4, representing 29% of headcount.
- Aug 15, 2026
Grew 40% QoQ, from 10 to 14 employees.
For institutional investors. Book with your work email.
Cyclana Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cyclana Bio's valuation, stock price, and market status.
Is Cyclana Bio a public or private company?
Cyclana Bio is a private company.
What is the current stock price of Cyclana Bio?
Cyclana Bio is a private company, so its shares have no public market price. Caplight tracks Cyclana Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cyclana Bio worth (valuation)?
Valuation information for Cyclana Bio is not publicly available.
Can I buy Cyclana Bio stock?
Cyclana Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cyclana Bio's last funding round?
Cyclana Bio's most recent funding round was pre_seed on October 20, 2025.
Who are the main investors in Cyclana Bio?
Key investors in Cyclana Bio include NFX, Eka Ventures.
Will Cyclana Bio IPO soon?
No public IPO plans have been announced for Cyclana Bio.
How can I track Cyclana Bio secondary market activity?
Caplight tracks bids, offers, and trades in Cyclana Bio's shares on secondary markets.